Judith V. Hobrath

ORCID: 0000-0002-5399-5625
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Cancer therapeutics and mechanisms
  • Computational Drug Discovery Methods
  • Biochemical and Molecular Research
  • Inflammatory mediators and NSAID effects
  • Estrogen and related hormone effects
  • Receptor Mechanisms and Signaling
  • Synthesis and biological activity
  • Immune Cell Function and Interaction
  • Chemical Synthesis and Analysis
  • RNA and protein synthesis mechanisms
  • Adenosine and Purinergic Signaling
  • T-cell and B-cell Immunology
  • Neurotransmitter Receptor Influence on Behavior
  • Cancer Mechanisms and Therapy
  • Microbial Natural Products and Biosynthesis
  • NF-κB Signaling Pathways
  • Endoplasmic Reticulum Stress and Disease
  • Neuropeptides and Animal Physiology
  • Trypanosoma species research and implications
  • Vitamin C and Antioxidants Research
  • Adrenal Hormones and Disorders
  • bioluminescence and chemiluminescence research
  • PI3K/AKT/mTOR signaling in cancer
  • Fibroblast Growth Factor Research

University of Dundee
2016-2020

Wellcome Centre for Anti-Infectives Research
2019-2020

University of Alabama at Birmingham
2018

Division of Chemistry
2015

Southern Research Institute
2008-2014

University of Michigan–Ann Arbor
2006

Visceral leishmaniasis (VL), caused by the protozoan parasites Leishmania donovani and infantum, is one of major parasitic diseases worldwide. There an urgent need for new drugs to treat VL, because current therapies are unfit purpose in a resource-poor setting. Here, we describe development preclinical drug candidate, GSK3494245/DDD01305143/compound 8, with potential this neglected tropical disease. The compound series was discovered repurposing hits from screen against related parasite...

10.1073/pnas.1820175116 article EN cc-by Proceedings of the National Academy of Sciences 2019-04-08

Melatonin is widely present in Nature. It has pleiotropic activities, part mediated by interactions with high-affinity G-protein-coupled melatonin type 1 and 2 (MT1 MT2) receptors or under extreme conditions, e.g., ischemia/reperfusion. In pharmacological concentrations, it given to counteract the massive damage caused MT1- MT2-independent mechanisms. The aryl hydrocarbon receptor (AhR) a perfect candidate for mediating latter effects because structural similarity its natural ligands,...

10.3390/ijms242015496 article EN International Journal of Molecular Sciences 2023-10-23

Abstract Nonsteroidal anti-inflammatory drugs such as sulindac have shown promising antineoplastic activity, although toxicity from cyclooxygenase (COX) inhibition and the suppression of prostaglandin synthesis limits their use for chemoprevention. Previous studies concluded that mechanism responsible activity may be COX independent. To selectively design out inhibitory sulfide (SS), in silico modeling were done revealed crucial role carboxylate moiety COX-1 COX-2 binding. These prompted a...

10.1158/1940-6207.capr-09-0001 article EN Cancer Prevention Research 2009-05-27

Abstract Using LC/qTOF-MS we detected lumisterol, 20-hydroxylumisterol, 22-hydroxylumisterol, 24-hydroxylumisterol, 20,22-dihydroxylumisterol, pregnalumisterol, 17-hydroxypregnalumisterol and 17,20-dihydroxypregnalumisterol in human serum epidermis, the porcine adrenal gland. The hydroxylumisterols inhibited proliferation of skin cells a cell type-dependent fashion with predominant effects on epidermal keratinocytes. They also melanoma both monolayer soft agar. 20-Hydroxylumisterol...

10.1038/s41598-017-10202-7 article EN cc-by Scientific Reports 2017-09-06

The antigen-presenting molecule MR1 presents riboflavin-based metabolites to Mucosal-Associated Invariant T (MAIT) cells. While egress the cell surface is ligand-dependent, ability of small-molecule ligands impact on cellular trafficking remains unknown. Arising from an in silico screen ligand-binding pocket, we identify one ligand, 3-([2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl]formamido)propanoic acid, DB28, as well analog, methyl...

10.1073/pnas.2003136117 article EN cc-by Proceedings of the National Academy of Sciences 2020-04-27

Antagonist and partial agonist modulators of the dopamine D3 receptor (D3R) have emerged as promising therapeutics for treatment substance abuse neuropsychiatric disorders. However, development druglike lead compounds with selectivity has been challenging because high sequence homology between D3R D2 (D2R). In this effort, we synthesized a series acylaminobutylpiperazines incorporating aza-aromatic units evaluated their binding functional activities at receptors. Docking studies results from...

10.1021/jm500801r article EN publisher-specific-oa Journal of Medicinal Chemistry 2014-08-15

The human pathogen Mycobacterium tuberculosis is the causative agent of pulmonary (TB), a disease with high worldwide mortality rates. Current treatment programs are under significant threat from multi-drug and extensively-drug resistant strains M. tuberculosis, it essential to identify new inhibitors their targets. We generated spontaneous mutants in bovis BCG presence 10× minimum inhibitory concentration (MIC) compound 1, previously identified potent inhibitor mycobacterial growth culture....

10.1371/journal.pone.0113568 article EN cc-by PLoS ONE 2014-11-19

Tuberculosis represents a significant public health crisis. There is an urgent need for novel molecular scaffolds against this pathogen. We screened small library of marine-derived compounds shikimate kinase from Mycobacterium tuberculosis (MtSK), promising target antitubercular drug development. Six manzamines previously shown to be active M. were characterized as MtSK inhibitors: manzamine A (1), 8-hydroxymanzamine (2), E (3), F (4), 6-deoxymanzamine X (5), and 6-cyclohexamidomanzamine...

10.1021/acs.biochem.8b00231 article EN Biochemistry 2018-07-31

A variety of commercial analogs and a newer series Sulindac derivatives were screened for inhibition M. tuberculosis (Mtb) in vitro specifically as inhibitors the essential mycobacterial tubulin homolog, FtsZ. Due to ease preparing diverse favorable vivo pharmacokinetic toxicity profile representative analog, scaffold may be useful further development against Mtb with respect bacterial growth selective activity FtsZ versus mammalian tubulin. Further discovery efforts will require separating...

10.1371/journal.pone.0164100 article EN cc-by PLoS ONE 2016-10-21

A highly reproducible and robust cell-based high-throughput screening (HTS) assay was adapted for of small molecules antiviral activity against influenza virus strain A/Vietnam/1203/2004 (H5N1). The NIH Molecular Libraries Small Molecule Repository (MLSMR) Screening Centers Network (MLSCN) 100,000-compound library screened at 50 µM. "hit" rate (>25% inhibition the viral cytopathic effect) from single-dose screen 0.32%. hits were evaluated their activity, cell toxicity, selectivity in...

10.1177/1087057110384613 article EN cc-by-nc-nd SLAS DISCOVERY 2010-11-09

Abstract Malignant gliomas have low survival expectations regardless of current treatments. Nonsteroidal anti‐inflammatory drugs (NSAIDs) prevent cell transformation and slow cancer growth by mechanisms independent cyclooxygenase (COX) inhibition. Certain NSAIDs trigger the endoplasmic reticulum stress response (ERSR), as revealed upregulation molecular chaperones such GRP78 C/EBP homologous protein (CHOP). Although celecoxib (CELE) inhibits sarcoendoplasmic Ca 2+ ATPase (SERCA), an effect...

10.1002/jnr.23169 article EN Journal of Neuroscience Research 2012-12-30

Tuberculosis (TB) remains a leading cause of mortality worldwide. With the emergence multidrug resistant TB, extensively drug TB and HIV-associated it is imperative that new targets be identified. The potential Mycobacterium tuberculosis inosine monophosphate dehydrogenase (IMPDH) as novel target was explored in present study. IMPDH exclusively catalyzes conversion (IMP) to xanthosine (XMP) presence cofactor nicotinamide adenine dinucleotide (NAD(+)). Although enzyme dehydrogenase, does not...

10.1371/journal.pone.0033886 article EN cc-by PLoS ONE 2012-03-29

In this letter we report first nonpeptide inhibitors of hepatocyte growth factor (HGF) activation. These compounds inhibit the three proteases (matriptase, hepsin, and HGF activator) required for maturation. We show that 6, 8a, 8b, 8d block activation fibroblast-derived pro-HGF, thus preventing fibroblast-induced scattering DU145 prostate cancer cells. Compound 6 (SRI 31215) is very soluble (91 μM) has excellent microsome stability (human t1/2 = 162 min; mouse 296 min). an in vivo 5.8 h...

10.1021/acsmedchemlett.5b00357 article EN ACS Medicinal Chemistry Letters 2015-12-22

Sulindac is a non-steroidal anti-inflammatory drug (NSAID) that has shown significant anticancer activity. sulfide amide (1) possessing greatly reduced COX-related inhibition relative to sulindac displayed in vivo antitumor activity was comparable human colon tumor xenograft model. Inspired by these observations, panel of diverse derivatives have been synthesized and their probed against three cancer cell lines (prostate, breast). A neutral analog, compound 79 identified with potency lead 1...

10.1016/j.bmcl.2017.09.022 article EN cc-by-nc-nd Bioorganic & Medicinal Chemistry Letters 2017-09-13

As part of an ongoing program to study the anticancer activity non-steroidal anti-inflammatory drugs (NSAIDs) through generating diversity libraries multiple NSAID scaffolds, we synthesized a series amide derivatives and screened these sets against three cancer cell lines (prostate, colon breast) Wnt/β-catenin signaling. The evaluated analog show significant activity/cell proliferation inhibition, specific members inhibition

10.1007/s00044-017-2001-z article EN cc-by Medicinal Chemistry Research 2017-08-05

Activation of invariant natural killer T lymphocytes (iNKT cells) by α-galactosylceramide (α-GC) elicits a range pro-inflammatory or anti-inflammatory immune responses. We report the synthesis and characterization series α-GC analogues with acyl chains varying length terminal benzophenone. These bound efficiently to glycolipid antigen presenting protein CD1d, upon photoactivation formed stable CD1d-glycolipid covalent conjugates. Conjugates benzophenone α-GCs soluble cell-bound CD1d proteins...

10.1021/acs.bioconjchem.8b00484 article EN Bioconjugate Chemistry 2018-08-07

Neuronal noncytokine-dependent p50/p65 nuclear factor-κB (the primary NF-κB complex in the brain) activation has been shown to exert neuroprotective actions. Thus neuronal of could represent a viable target. We have developed cell-based assay able detect expression enhancement, and through its use we identified small molecules up-regulate hence trigger neurons. successfully screened approximately 300,000 compounds 1,647 active compounds. Cluster analysis structures within hit population...

10.1002/jnr.22526 article EN Journal of Neuroscience Research 2010-11-02
Coming Soon ...